CACI International, Inc. vs NVIDIA Corporation — Stock Comparison
Q·Score Breakdown
7.2
Bullish
Overall
9.1
Very Bullish
Quality
Health
Growth
Valuation
Sentiment
CACI
Consensus analyst target of $696.46 is 36% above current price.
⚠ weak profitability metrics drag quality score.
NVDA
Clean balance sheet with low leverage (0.1× debt-to-equity).
Analyst Consensus
BUY
Target $696.46 (+35.7%)
13 analysts
BUY
Target $269.17 (+35.6%)
57 analysts
Fundamentals
CACI
NVDA
21.2×
Trailing P/E
40.5×
16.4×
Forward P/E
17.7×
5.9%
Profit Margin
55.6%
32.6%
Gross Margin
71.1%
13.4%
ROE
101.5%
8.5%
Revenue Growth
73.2%
17.6%
Earnings Growth
95.6%
0.63
Beta
2.33
—
Price / Book
—
$11.3B
Market Cap
$4.82T
$410 – $684
52-Week Range
$111 – $217
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →